These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24029306)

  • 21. Radiofrequency thermal ablation of renal graft neoplasms: Case series and literature review.
    Iezzi R; Posa A; Romagnoli J; Salerno MP; Carchesio F; Veltri G; Spagnoletti G; Citterio F; Manfredi R
    Clin Transplant; 2018 Dec; 32(12):e13432. PubMed ID: 30357920
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute tubular necrosis following radiofrequency ablation of a renal cell carcinoma.
    Wah TM; Irving HC
    Cardiovasc Intervent Radiol; 2009 May; 32(3):591-2. PubMed ID: 17985183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma.
    Welch BT; Callstrom MR; Morris JM; Kurup AN; Schmit GD; Weisbrod AJ; Lohse CM; Kohli M; Costello BA; Olivier KR; Thompson RH; Boorjian SA; Atwell TD
    J Urol; 2014 Aug; 192(2):357-63. PubMed ID: 24631107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous imaging-guided radiofrequency ablation of small renal cell carcinoma: techniques and outcomes of 24 treatment sessions in 18 consecutive patients.
    Popovic P; Surlan-Popovic K; Lukic S; Mijailovic M; Jankovic S; Kuhelj D
    J BUON; 2011; 16(1):127-32. PubMed ID: 21674863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How I do it: percutaneous radiofrequency ablation (RFA).
    Sorokin I; Chamarthy M; Cadeddu JA
    Can J Urol; 2017 Feb; 24(1):8679-8683. PubMed ID: 28263138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes.
    Ramirez D; Ma YB; Bedir S; Antonelli JA; Cadeddu JA; Gahan JC
    J Endourol; 2014 Mar; 28(3):330-4. PubMed ID: 24156661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CT-guided radiofrequency ablation of renal cell carcinoma in a patient with solitary kidney after contralateral nephrectomy: a case report].
    Yasui K; Kanazawa S; Iguchi T; Fujiwara H; Hiraki Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Jan; 63(1):59-61. PubMed ID: 12645127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation of kidney tumours in patients with a solitary kidney.
    Prevoo W; van den Munckhof MP; Meinhardt W; Horenblas S; van den Bosch MA
    Clin Radiol; 2010 Mar; 65(3):230-6. PubMed ID: 20152280
    [No Abstract]   [Full Text] [Related]  

  • 31. Radiofrequency ablation used to treat select renal and adrenal tumors.
    Zuboy J
    Curr Treat Options Oncol; 2000 Jun; 1(2):93-4. PubMed ID: 12061373
    [No Abstract]   [Full Text] [Related]  

  • 32. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.
    Stern JM; Svatek R; Park S; Hermann M; Lotan Y; Sagalowsky AI; Cadeddu JA
    BJU Int; 2007 Aug; 100(2):287-90. PubMed ID: 17617136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Laguna MP
    J Urol; 2020 Jan; 203(1):27-28. PubMed ID: 31618159
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Oncologic Outcomes following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Cadeddu JA
    J Urol; 2020 Jan; 203(1):28. PubMed ID: 31618160
    [No Abstract]   [Full Text] [Related]  

  • 36. Current limitations of radiofrequency ablation in renal cell carcinoma.
    Jewett MA
    Urologe A; 2004 Sep; 43 Suppl 3():S122-3. PubMed ID: 15164179
    [No Abstract]   [Full Text] [Related]  

  • 37. CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma.
    Krokidis ME; Orsi F; Katsanos K; Helmberger T; Adam A
    Cardiovasc Intervent Radiol; 2017 Feb; 40(2):177-191. PubMed ID: 27987000
    [No Abstract]   [Full Text] [Related]  

  • 38. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax.
    Ahrar K; Matin S; Wallace MJ; Gupta S; Hicks ME
    AJR Am J Roentgenol; 2005 Jul; 185(1):86-8. PubMed ID: 15972404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
    El Dib R; Touma NJ; Kapoor A
    BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous radiofrequency ablation of small renal cell carcinoma: technique, complications, and outcomes.
    Popovic P; Lukic S; Mijailovic M; Salapura V; Garbajs M; Surlan Popovic K
    J BUON; 2012; 17(4):621-6. PubMed ID: 23335516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.